Silence Therapeutics to Present at Jefferies London Healthcare Conference

LONDON--(BUSINESS WIRE)-- Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced that Craig Tooman, Silence President and CEO, will present a corporate update at the Jefferies London Healthcare Conference on Wednesday, November 15th at 4:30 p.m. GMT.

The live webcast can be accessed via the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be available following the conference.

About Silence Therapeutics
Silence Therapeutics is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet need. Silence's proprietary mRNAi GOLD™ platform can be used to create siRNAs (short interfering RNAs) that precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence's wholly owned product candidates include zerlasiran designed to address the high and prevalent unmet medical need in reducing cardiovascular risk in people born with high levels of lipoprotein(a) and SLN124 designed to address hematological diseases. Silence also maintains ongoing research and development collaborations with AstraZeneca, Mallinckrodt Pharmaceuticals, and Hansoh Pharma, among others. For more information, please visit https://www.silence-therapeutics.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231108841473/en/

Silence Therapeutics plc
Gem Hopkins, Head of IR and Corporate Communications
[email protected]
Tel: +1 (646) 637-3208

Source: Silence Therapeutics plc

You May Also Be Interested In

• Norton Manx R Earns Landmark International Design Excellence Award for Reimagining the Superbike
• Pump.Fun Price Prediction: Memecoin Traders Buy MemeToro and PUMP For Upcoming Crypto Bull Run
• From Whitelist to the Next Meme Wave: Apeing Eyes the Best Meme Coin Spot While Snek and Pepe Hold Their Ground